Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System
October 25, 2018 08:30 ET
|
Fluidigm Corporation
Providing the largest source of standardized, multi-omic immune data from healthy human subjects to accelerate translational research SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) --...
ETST Launches Cannabis Therapeutics Website, Shares Updates on their CBD-Based Nutraceutical Patents, & Hints on New Products Launching May 2017
April 20, 2017 07:55 ET
|
Earth Science Tech, Inc.
Hollywood, April 20, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST), an innovative biotech company focused on cannabis (industrial hemp), cannabinoid research and development,...
ETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.
March 06, 2017 07:45 ET
|
Earth Science Tech, Inc.
Hollywood, March 06, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and...
Earth Science Tech Completes New Scientific Formulation of its All Natural Bioceutical Line and Introduces Cutting-Edge Advanced Hemp CBD (Cannabidiol) Stacking Systems for Health and Well-Being
January 07, 2016 08:00 ET
|
Earth Science Tech, Inc.
Boca Raton, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Bioceuticals are the nutritional building blocks necessary for making new DNA and RNA, which have to be obtained from our diets,...
Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors
December 16, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today further progress on developing Ampligen® (rintatolimod)...
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26
June 25, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, June 25, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), will present a corporate update on their Advanced Therapies for the Human...
FFF Enterprises Takes Top Honors in 2012 MarCom Awards Competition
November 13, 2012 09:00 ET
|
FFF Enterprises
TEMECULA, CA--(Marketwire - Nov 13, 2012) - FFF Enterprises, Inc., the nation's largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals and publisher...
Stellar Biotechnologies Presented at World Congress of Marine Biotechnology
September 26, 2012 09:45 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Sep 26, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) today announced that Frank Oakes, President...
Researchers to Present Results From Two VIRxSYS HIV Studies at the 6th International AIDS Society Meeting
June 28, 2011 10:06 ET
|
VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Jun 28, 2011) - VIRxSYS Corporation today announced that data from two HIV studies will be presented at the 6th International AIDS Society Conference on HIV...
Immunitor Publishes Interim Data From Phase IIb imm01 TB Trial
December 30, 2010 04:41 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Dec. 30, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has published data from the first half of the 120-patient imm01 clinical...